Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04065035 · ClinicalTrials.gov registry record · NA
A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming
A NA study, sponsored by Revision Skincare.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT04065035: Completed NA study, sponsored by Revision Skincare.
NCT04065035 is a NA study that has completed, run by Revision Skincare. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04065035, a NA study, has completed, sponsored by Revision Skincare.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
This single-center, split-body, double-blind, randomized, controlled clinical trial was conducted to assess the efficacy and tolerance of a topical firming body moisturizer when used over the course of 12 weeks by women with mild to moderate sagging, crepey skin, and overall photodamage on the upper arms. A total of 40 subjects completed study participation which included 10 subjects in the biopsy subgroup.
Primary Outcome
Investigator assessed the participants' skin crepiness using a 10-point scale where none 0 = skin appears smooth with no crinkling to severe 9 = prominent, extensive crinkly texture at baseline, week 4, 8, and 12. A decrease in score indicates improvement.
Interventions
- OTHER Sunscreen
- OTHER Topical Body Firming Moisturizer
- OTHER Body Cleanser
- OTHER Placebo Moisturizer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2018-12-13 |
| Est. Completion | 2019-07-17 |
| Phase | NA |
What the finished NCT04065035 record still lists
NCT04065035 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which Sunscreen is the first listed.
NCT04065035 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04065035 about?
NCT04065035 is a clinical study titled "A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming". This single-center, split-body, double-blind, randomized, controlled clinical trial was conducted to assess the efficacy and tolerance of a topical firming body moisturizer when used over the course of 12 weeks by women with mild to moderate sagging, crepey skin, and overall photodamage on the upper...
What is the current status of trial NCT04065035?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2018-12-13. Estimated completion is 2019-07-17.
What interventions are being tested in trial NCT04065035?
The interventions under investigation include: Sunscreen (OTHER), Topical Body Firming Moisturizer (OTHER), Body Cleanser (OTHER), Placebo Moisturizer (OTHER).
Who is sponsoring clinical trial NCT04065035?
This trial is sponsored by Revision Skincare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04065035's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI